Almac Jobs Boost for Northern Ireland
February 5, 2009
128 new positions across Almac group
The Almac Group, which is based in Craigavon, has created almost 100 full time jobs in Northern Ireland in the first two months of 2009. Twenty full time positions were filled in January with an additional 25 new recruits due to come on board this month. A further 54 jobs have already been advertised. Over 90% of the new full time positions are aimed at graduates, with scientists in particular being sought by the pharmaceutical company. Almac expanded its workforce by 250 in total last year. This brings our Northern Ireland total to 1559 and 2422 worldwide.
The new jobs have been created across the range of Almac’s research and pharmaceutical development activities. Chief Executive Alan Armstrong is confident that 2009 will be a year of significant growth for the company. The continued growth in employee numbers also extends to the US operation of Almac where 52 new recruits have joined the company since the beginning of this year.
“Last year we grew our employee numbers by 15% in Northern Ireland. In the first two months of this year we will have recruited 99 full time staff and an additional 28 temporary workers. This is down to the continued success of the company in the pharmaceutical sector and particularly in the clinical trial and research areas. Almac is a Northern Ireland organization which is operating at the very highest level of pharmaceutical development.”
“The vast majority of positions we are seeking to fill require a third level qualification so despite the negativity which may exist there are opportunities for local graduates to enter employment. We are particularly looking for graduates qualified in scientific disciplines. We continue to invest in both our people and our structures. Here in Craigavon we have invested in new IT systems and infrastructure. Later this year we will open a new analytical annex, while in Philadelphia considerable progress has been made on our new US headquarters. We believe strongly in both the quality of our staff and the service we provide for our clients. The success of this business is driven by its employees, and this year will see an ever increasing number joining the Almac family.”
Brendan Mulgrew / Carl Whyte
02890 339949 / 07767 393252
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, product development, clinical trial supply and technology (IVRS/EDC), to commercial-scale manufacture. Almac provides services to over 600 companies including all the world leaders in the pharmaceutical and biotech sectors.
The company has over 2,200 employees and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company’s new $100m North American Headquarters started in July 08 and is expected to be completed 2010.